DZ Bank
LGND icon

DZ Bank’s Ligand Pharmaceuticals LGND Stock Holding History

DZ Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,859
Closed -$918K – 1076
2023
Q4 		$918K Hold
12,859
– – ﹤0.01% 669
2023
Q3 		$771K Hold
12,859
– – ﹤0.01% 678
2023
Q2 		$927K Buy
12,859
+7,367
+134% +$553K ﹤0.01% 669
2023
Q1 		$404K Buy
+5,492
New +$390K ﹤0.01% 771

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank's LGND Position: Q1 2024 in Review

DZ Bank sold out of Ligand Pharmaceuticals (LGND) in Q1 2024, closing a stake of 12,859 shares — an estimated $918K sold.

DZ Bank first reported a position in LGND in Q1 2023 and held it in 4 quarters. The position peaked at $927K in Q2 2023. 222 funds tracked by Wall St. Rank hold LGND as of Q1 2024.

  • DZ Bank reported no remaining Ligand Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • DZ Bank sold 12,859 Ligand Pharmaceuticals shares in Q1 2024, an estimated $918K.
  • DZ Bank first reported a position in Ligand Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • DZ Bank's Ligand Pharmaceuticals position peaked at $927K in Q2 2023.
  • 222 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2024.

Based on DZ Bank's 13F filing for Q1 2024, filed 15 May 2024.